EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Advances in mass spectrometry imaging for spatial cancer metabolomics

Xin Ma iD, Facundo M Fernández iD

Mass Spectrometry Reviews · 2024-03 · 43 (2) · 235-268

DOI: 10.1002/mas.21804 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Mass Spectrometry Reviews, online erschienen am 06.09.2022. Verfasst von Xin Ma und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Biochemistry and Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Artificial Intelligence, Neoplasms. Die Arbeit wurde bisher 189-mal zitiert (Crossref) und nennt 328 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mass spectrometry (MS) has become a central technique in cancer research. The ability to analyze various types of biomolecules in complex biological matrices makes it well suited for understanding biochemical alterations associated with disease progression. Different biological samples, including serum, urine, saliva, and tissues have been successfully analyzed using mass spectrometry. In particular, spatial metabolomics using MS imaging (MSI) allows the direct visualization of metabolite distributions in tissues, thus enabling in‐depth understanding of cancer‐associated biochemical changes within specific structures. In recent years, MSI studies have been increasingly used to uncover metabolic reprogramming associated with cancer development, enabling the discovery of key biomarkers with potential for cancer diagnostics. In this review, we aim to cover the basic principles of MSI experiments for the nonspecialists, including fundamentals, the sample preparation process, the evolution of the mass spectrometry techniques used, and data analysis strategies. We also review MSI advances associated with cancer research in the last 5 years, including spatial lipidomics and glycomics, the adoption of three‐dimensional and multimodal imaging MSI approaches, and the implementation of artificial intelligence/machine learning in MSI‐based cancer studies. The adoption of MSI in clinical research and for single‐cell metabolomics is also discussed. Spatially resolved studies on other small molecule metabolites such as amino acids, polyamines, and nucleotides/nucleosides will not be discussed in the context.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceNeoplasmsHumansSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationMetabolomicsLipidomics

Stichwörter der Autor:innen

DESIMALDISIMScancerglycanslipidsmass spectrometry imagingspatial metabolomics

Autor:innen und Institutionen

  • School of Chemistry and Biochemistry and Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, Georgia, USA.

ORCID-Profile: Xin Ma, Facundo M Fernández

Förderung

  • NCI NIH HHS
  • National Science Foundation

Zitieren

APA

Ma, X., & Fernández, F. M. (2024). Advances in mass spectrometry imaging for spatial cancer metabolomics. Mass Spectrometry Reviews, 43(2), 235-268. https://doi.org/10.1002/mas.21804

Vancouver

Ma X, Fernández FM. Advances in mass spectrometry imaging for spatial cancer metabolomics. Mass Spectrometry Reviews. 2024;43(2):235-268. doi:10.1002/mas.21804

BibTeX
@article{Ma2024,
  author = {Ma, Xin and Fernández, Facundo M},
  title = {Advances in mass spectrometry imaging for spatial cancer metabolomics},
  journal = {Mass Spectrometry Reviews},
  year = {2024},
  volume = {43},
  number = {2},
  pages = {235--268},
  doi = {10.1002/mas.21804}
}
Kostenlos starten →